Functional cloning of drug resistance genes from retroviral cDNA libraries

Biochemical and Biophysical Research Communications

Volumn 309, Issue 3, 2003, Pages 605-611

  Bosma, Peter T ^a,c   Van Eert, Simone J ^a   Jaspers, Nicolaas G J ^b   Stoter, Gerrit ^a   Nooter, Kees ^a  

^a JOSEPHINE NEFKENS INSTITUTE   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alternative splicing; Drug resistance; ERCC1; Functional cloning; Retrovirus

Indexed keywords

CISPLATIN; EXCISION REPAIR CROSS COMPLEMENTING PROTEIN 1; PROTEIN; RETROVIRUS VECTOR; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CULTURE; CHEMOTHERAPY; CONTROLLED STUDY; DNA LIBRARY; DRUG SENSITIVITY; EMBRYO; EXCISION REPAIR; FIBROBLAST; GENE; GENE CONSTRUCT; GENE EXPRESSION; GENE LOCATION; GENE OVEREXPRESSION; GENE SEQUENCE; GENE THERAPY; HUMAN; MAMMAL; MOLECULAR CLONING; MOLECULAR DYNAMICS; NONHUMAN; PHENOTYPE; PLACENTA; PRIORITY JOURNAL; RNA SPLICING; TARGET CELL; VALIDATION PROCESS;

MAMMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0042831442     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2003.08.042     Document Type: Article

References (28)

1. Duan Z., Lamendola D.E., Seiden M.V. cDNA technologies and their application to drug resistance research: power, potential and problems. Drug Resist. Updates. 3:2000;277-282.
2. Biedler J.L. Drug resistance: genotype versus phenotype. Cancer Res. 54:1994;666-678.
3. Perez R.P. Cellular and molecular determinants of cisplatin resistance. Eur. J. Cancer. 34:1998;1535-1542.
4. Burger H., Capello A., Schenk P.W., Stoter G., Brouwer J., Nooter K. A genome-wide screening in Saccharomyces cerevisiae for genes that confer resistance to the anticancer agent cisplatin. Biochem. Biophys. Res. Commun. 269:2000;767-774.
5. Schenk P.W., Boersma A.W.M., Brandsma J.A., den Dulk H., Burger H., Stoter G., Brouwer J., Nooter K. SKY1 is involved in cisplatin-induced cell kill in Saccharomyces cerevisiae and inactivation of its human homologue SRPK1 induces cisplatin resistance in a human ovarian carcinoma cell line. Cancer Res. 61:2001;6982-6986.
6. Schenk P.W., Boersma A.W.M., Brok M., Burger H., Stoter G., Nooter K. Inactivation of the Saccharomyces cerevisiae SKY1 gene induces a specific modification of the yeast anticancer drug sensitivity profile accompanied by a mutator phenotype. Mol. Pharmacol. 61:2002;659-666.
7. ARF and inhibits senescence J. Biol. Chem. 277:2002;6567-6572.
8. Fletcher B.S., Dragstedt C., Notterpek L., Nolan G.P. Functional cloning of SPIN-2, a nuclear anti-apoptotic protein with roles in cell cycle progression. Leukemia. 16:2002;1507-1518.
9. Rodriguez C., Huang L.J.S., Son J.K., McKee A., Xiao Z., Lodish H.F. Functional cloning of the proto-oncogene brain factor-1 (BF-1) as a Smad-binding antagonist of transforming growth factor-β signaling. J. Biol. Chem. 276:2001;30224-30230.
10. Weeda G., Donker I., de Wit J., Morreau H., Janssens R., Vissers C.J., Nigg A., van Steeg H., Bootsma D., Hoeijmakers J.H.J. Disruption of mouse ERCC1 results in a novel repair syndrome with growth failure, nuclear abnormalities and senescence. Curr. Biol. 7:1997;427-439.
11. Sijbers A.M., de Laat W.L., Ariza R.R., Biggerstaff M., Wei Y.F., Moggs J.G., Carter K.C., Shell B.K., Evans E., de Jong M.C., Rademakers S., de Rooij J., Jaspers N.G.J., Hoeijmakers J.H.J., Wood R.D. Xeroderma pigmentosum group F caused by a defect in a structure-specific DNA repair endonuclease. Cell. 86:1996;811-822.
12. de Laat W.L., Sijbers A.M., Odijk H., Jaspers N.G.J., Hoeijmakers J.H.J. Mapping of interaction domains between human repair proteins ERCC1 and XPF. Nucleic Acids Res. 26:1998;4146-4152.
13. de Laat W.L., Jaspers N.G.J., Hoeijmakers J.H.J. Molecular mechanism of nucleotide excision repair. Genes Dev. 13:1999;768-785.
14. Swift S.E., Lorens J.B., Achacoso P., Nolan G.P. Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Coligan J.E., Kruisbeek A.M., Margulies D.H., Shevach E.M., Strober W. Current Protocols in Immunology. vol. 10.17C:1999;14-29 Wiley, New York.
15. Hartley J.W., Rowe W.P. Naturally occurring murine leukemia viruses in wild mice: characterization of a new "amphotropic" class. J. Virol. 19:1976;19-25.
16. Berns K., Hijmans E.M., Koh E., Daley G.Q., Bernards R. A genetic screen to identify genes that rescue the slow growth phenotype of c-myc null fibroblasts. Oncogene. 19:2000;3330-3334.
17. van Duin M., de Wit J., Odijk H., Westerveld A., Yasui A., Koken M.H.M., Hoeijmakers J.H.J., Bootsma D. Molecular characterization of the human excision repair gene ERCC-1: cDNA cloning and amino acid homology with the yeast DNA repair gene RAD10. Cell. 44:1986;913-923.
18. Rogozin I.B., Milanesi L. Analysis of donor splice sites in different eukaryotic organisms. J. Mol. Evol. 45:1997;50-59.
19. Mathé C., Sagot M.F., Schiex T., Rouzé P. Current methods of gene prediction, their strengths and weaknesses. Nucleic Acids Res. 30:2002;4103-4117.
20. Sijbers A.M., van der Spek P.J., Odijk H., van den Berg J., van Duin M., Westerveld A., Jaspers N.G.J., Bootsma D., Hoeijmakers J.H.J. Mutational analysis of the human nucleotide excision repair gene ERCC1. Nucleic Acids Res. 24:1996;3370-3380.
21. Li L., Elledge S.J., Peterson C.A., Bales E.S., Legerski R.J. Specific association between the human DNA repair proteins XPA and ERCC1. Proc. Natl. Acad. Sci. USA. 91:1994;5012-5016.
22. Vile R.G., Tuszynski A., Castleden S. Retroviral vectors. From laboratory tools to molecular medicines. Rapley R., Walker J.M. Molecular Biomethods Handbook. 1998;193-218 Humana Press, Totowa.
23. Bender M.A., Palmer T.D., Gelinas R.E., Miller A.D. Evidence that the packaging signal of Moloney murine leukemia virus extends into the gag region. J. Virol. 61:1987;1639-1646.
24. Armentano D., Yu S.F., Kantoff P.W., Von Ruden T., Anderson W.F., Gilboa E. Effect of internal viral sequences on the utility of retroviral vectors. J. Virol. 61:1987;1647-1650.
25. Pambalk K., Hohenadl C., Salmons B., Günzburg W.H., Renner M. Specific packaging of spliced retroviral vector transcripts lacking the ψ-region. Biochem. Biophys. Res. Commun. 293:2002;239-246.
26. Burset M., Seledtsov I.A., Solovyev V.V. Analysis of canonical and non-canonical splice sites in mammalian genomes. Nucleic Acids Res. 28:2000;4364-4375.
27. Morgenstern J.P., Land H. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. Nucleic Acids Res. 18:1990;3587-3596.
28. Miller A.D., Rosman G.J. Improved retroviral vectors for gene transfer and expression. Biotechniques. 7:1989;980-982.